A documentary about psilocybin-assisted therapy is coming to a Las Cruces theater this Friday, as New Mexico moves toward opening its legislatively created medical psilocybin program in December. The film, titled Journeys, screens with doors opening at 5 p.m.
According to KVIA, Journeys explores emerging therapeutic approaches to psychedelics, sharing personal stories and beliefs about healing, consciousness and transformation. The station reports that psilocybin therapy — commonly known by its association with magic mushrooms — is described by some as powerful, and even a potential game changer for treating addiction and PTSD. Director Christopher Cramer told the station he wants the film to inform people about treatments that are available and working for many, adding that he decided to make the documentary after a life-changing conversation with a friend's mother.
Following the screening, a panel discussion will bring together the filmmakers and New Mexico State Senator Jeff Steinborn, the same report notes. The two-hour film was directed by Cramer, with Carolyn Armitage as its producer, and it was supported by Armitage, founder and CEO of Wealth Management Consulting, who backed the project after using a large dose of psilocybin several years earlier and describing healing childhood trauma, according to WealthManagement.com. Before its Las Cruces stop, the film had already reached global audiences: as reported by EIN Presswire, Journeys was released on Apple TV, Amazon, Google Play, Vimeo and Dish back in April.
New Mexico's Legislative Path to Legal Psilocybin
New Mexico's Legislative Path to Legal Psilocybin New Mexico is the third state to legalize psychedelic-assisted therapy, per the KVIA report, which is used for treating mental health conditions, trauma and end-of-life care. The state's Medical Psilocybin Act took legal effect in June 2025, after Governor Michelle Lujan Grisham signed it into law that April, the station notes. The bill passed the state Senate by a 33-4 vote and was transmitted to the House, according to Marijuana Moment, which reports it was introduced by state Senator Jeff Steinborn alongside four co-sponsors.
The 2025 General Appropriation Act is discussed in a report from the University of New Mexico Office of Government & Community Relations. The law itself removes psilocybin and psilocin from Schedule I of New Mexico's Controlled Substances Act specifically for licensed therapeutic treatments, authorizing permitted clinicians to treat patients for PTSD, major treatment-resistant depression, substance use disorders and end-of-life care, per the New Mexico Legislature, which notes the statute also establishes a nine-member advisory board to review and recommend qualifying conditions.
Why New Mexico's Approach Stands Apart
Why New Mexico's Approach Stands Apart New Mexico became the third state to legalize psychedelic-assisted therapy, according to the UC Berkeley Center for the Science of Psychedelics. A separate reference on New Mexico's legal history involving the substance appears in the record.
The New Mexico Department of Health will launch the Medical Psilocybin Program in December 2026, a full year ahead of the deadline originally set by state lawmakers, per KVIA's reporting. As part of that rulemaking process, the law requires tribal consultation.
A National Backdrop of Rising Use
A National Backdrop of Rising Use The push for regulated access has a national backdrop. For Las Cruces residents curious about how that national trend intersects with New Mexico's own program, Friday's screening and panel discussion offer a rare local chance to hear directly from the filmmakers and a state senator who helped write the law. More information on the film is available at journeysfilm.com.
